Erietta Polychronopoulou
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Erietta Polychronopoulou has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Aikaterini Damianaki
Nephrology Department, Hippokration General Hospital, 11527 Athens, Greece
2 shared publications - Grégoire Wuerzner
Lausanne University Hospital
2 shared publications - Mariëlle Hendriks-Balk
Department of Medicine, Service of Nephrology and Hypertension, University Hospital of Lausanne and University of Lausanne, Lausanne, Switzerland
2 shared publications - Menno Pruijm
Service of Nephrology, University Hospital of Lausanne and University of Lausanne, Lausanne, Switzerland
2 shared publications Anna Vybornova
Aktiia SA, Neuchâtel, Switzerland
1 shared publicationArlene Wurzner-Ghajarzadeh
CHUV University Hospital of Lausanne, Lausanne, SWITZERLAND
1 shared publication
Latest Publications
- Open Access
- 4 February 2025
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 14 (3) , e039306
In Patients With Hypertension, the Cortical Perfusion Index Measured by Contrast Enhanced Ultrasound Reveals a Sexual Dimorphism
Background: Arterial hypertension is characterized by microvasculature changes and reduced tissue perfusion. It is unknown whether a sexual dimorphism of renal microcirculation is present in patients with arterial hypertension. We aimed to compare the cortical microcirculation in women and men with hypertension and to evaluate their response to sympathetic stimulation with a cold pressor test (CPT). Methods: The cortical perfusion index (PI) measured by contrast‐enhanced ultrasonography was used as a proxy of renal microcirculation. We measured the PI at rest and during a 2‐minute CPT in patients with arterial hypertension. We used a linear mixed‐model analysis to study the effect of sex, the CPT, and their interaction on the PI. Results: Thirty‐two participants were included (34% women). Age and body mass index were similar in both groups. Median PI was higher in women (2344 [interquartile range, 1553–2685 arbitrary units]) than men (1285 [interquartile range, 591–1741 arbitrary units], P =0.009). The CPT increased the PI in both groups; however, the magnitude of the response to CPT was similar in both sexes. Conclusions: Women with arterial hypertension have a higher cortical microperfusion than men, while their microvascular reactivity to a CPT appears to be similar. This sexual dimorphism may have an impact on renal function decline, which needs further investigation.
- 4 February 2025
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 14 (3) , e039306
Open AccessIn Patients With Hypertension, the Cortical Perfusion Index Measured by Contrast Enhanced Ultrasound Reveals a Sexual Dimorphism
Background: Arterial hypertension is characterized by microvasculature changes and reduced tissue perfusion. It is unknown whether a sexual dimorphism of renal microcirculation is present in patients with arterial hypertension. We aimed to compare the cortical microcirculation in women and men with hypertension and to evaluate their response to sympathetic stimulation with a cold pressor test (CPT). Methods: The cortical perfusion index (PI) measured by contrast‐enhanced ultrasonography was used as a proxy of renal microcirculation. We measured the PI at rest and during a 2‐minute CPT in patients with arterial hypertension. We used a linear mixed‐model analysis to study the effect of sex, the CPT, and their interaction on the PI. Results: Thirty‐two participants were included (34% women). Age and body mass index were similar in both groups. Median PI was higher in women (2344 [interquartile range, 1553–2685 arbitrary units]) than men (1285 [interquartile range, 591–1741 arbitrary units], P =0.009). The CPT increased the PI in both groups; however, the magnitude of the response to CPT was similar in both sexes. Conclusions: Women with arterial hypertension have a higher cortical microperfusion than men, while their microvascular reactivity to a CPT appears to be similar. This sexual dimorphism may have an impact on renal function decline, which needs further investigation.
- Open Access
- 8 August 2023
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 39 (2) , 242-250
Contrast-enhanced ultrasonography reveals a lower cortical perfusion and a decreased renal flow reserve in hypertensive patients
Microvascular structural alteration and dysfunction is a hallmark of arterial hypertension. So far, the visualization and the quantification of renal microcirculation in humans has been hampered by the lack of non-nephrotoxic and non-invasive radiologic techniques. Contrast-enhanced ultrasonography (CEUS) is an appealing method to investigate renal microcirculation and has not been investigated in this setting. We aimed to compare renal microcirculation in normotensive (NT) and hypertensive (HT) participants using CEUS at rest and during a sympathetic stress test. We measured the renal perfusion index (PI, primary outcome), the renal resistive index (RRI), beat-to-beat systemic hemodynamics and plasma catecholamines before and during a 2-min cold pressor test (CPT) in NT and HT participants. Linear mixed model analysis was used to compare the effect of the CPT on the variables of interest. Seventy-three participants (32 HT) with normal kidney function were included. HT participants had a lower baseline PI compared with NT participants [median (interquartile range) 1476 (959–2155) arbitrary units (a.u.) vs 2062 (1438–3318) a.u., P < .001]. The CPT increased blood pressure, heart rate and catecholamines in all participants. The increase in PI observed in NT during the CPT was blunted in HT [+504 (117–920) a.u. vs +1159 (678–2352) a.u in NT, interaction P = .013]. Age, sex and body mass index did not modify these results. HT patients had a lower basal renal cortical perfusion. During the cold pressor test, HT participants had a smaller increase in the PI, suggesting that renal cortical flow reserve is impaired.
- 8 August 2023
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 39 (2) , 242-250
Open AccessContrast-enhanced ultrasonography reveals a lower cortical perfusion and a decreased renal flow reserve in hypertensive patients
Microvascular structural alteration and dysfunction is a hallmark of arterial hypertension. So far, the visualization and the quantification of renal microcirculation in humans has been hampered by the lack of non-nephrotoxic and non-invasive radiologic techniques. Contrast-enhanced ultrasonography (CEUS) is an appealing method to investigate renal microcirculation and has not been investigated in this setting. We aimed to compare renal microcirculation in normotensive (NT) and hypertensive (HT) participants using CEUS at rest and during a sympathetic stress test. We measured the renal perfusion index (PI, primary outcome), the renal resistive index (RRI), beat-to-beat systemic hemodynamics and plasma catecholamines before and during a 2-min cold pressor test (CPT) in NT and HT participants. Linear mixed model analysis was used to compare the effect of the CPT on the variables of interest. Seventy-three participants (32 HT) with normal kidney function were included. HT participants had a lower baseline PI compared with NT participants [median (interquartile range) 1476 (959–2155) arbitrary units (a.u.) vs 2062 (1438–3318) a.u., P < .001]. The CPT increased blood pressure, heart rate and catecholamines in all participants. The increase in PI observed in NT during the CPT was blunted in HT [+504 (117–920) a.u. vs +1159 (678–2352) a.u in NT, interaction P = .013]. Age, sex and body mass index did not modify these results. HT patients had a lower basal renal cortical perfusion. During the cold pressor test, HT participants had a smaller increase in the PI, suggesting that renal cortical flow reserve is impaired.
- Open Access
- 1 June 2022
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 40 (Suppl 1) , e92
VALIDATION OF THE OPTICAL AKTIIA BRACELET IN DIFFERENT BODY POSITIONS FOR THE PERSISTENT MONITORING OF BLOOD PRESSURE
Objective: The diagnosis of hypertension and the adjustment of antihypertensive drugs are evolving from repeated isolated measurements performed at the physician offices to the full phenotyping of patients in real-life conditions. Indeed, epidemiologic data show that prediction of risk is largely improved when blood pressure (BP) is measured out of the doctor’s office. Today, out-of-office measurements of BP are mostly performed by a series of self-measurements done at home over several days (HBPM monitoring), or automatically for 24 hours (ABPM monitoring). None of these approaches allow assessing and tracking the 24 hour hypertensive phenotype of patients in the long term. The aim of this study was to demonstrate that a wearable BP monitor (the CE-marked Aktiia Bracelet) can accurately estimate BP in the most common body positions of daily life and thus become a candidate solution for the long-term BP phenotyping of patients. Design and method: We recruited 91 patients with BP ranging from low to hypertensive levels and compared BP values from the Aktiia Bracelet against auscultatory reference values for four weeks at different body positions according to an extended and adapted ISO 81060-2 protocol. Results: The observed means and standard deviations of differences for systolic BP were of 0.46 ± 7.75 mmHg in the sitting position, -2.44 ± 10.15 mmHg in the lying, -3.02 ± 6.10 mmHg in the sitting with the device on the lap, and -0.62 ± 12.51 mmHg in the standing position. Differences for diastolic BP readings were respectively of 0.39 ± 6.86 mmHg, -1.93 ± 7.65 mmHg, 4.22 ± 6.56 mmHg and -4.85 ± 9.11 mmHg. For the sitting and relax position (for which the ISO 81060–2 performance criteria are applicable) the Aktiia Bracelet met criterion 1 and criterion 2. Conclusions: This study demonstrates that the optical Aktiia Bracelet can accurately estimate BP in the most common body positions compared to auscultation, although precision varies across positions. These findings pave the way to the use of this wearable device for the persistent monitoring of BP, and the further identification of individual BP phenotypes at scale.
- 1 June 2022
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 40 (Suppl 1) , e92
Open AccessVALIDATION OF THE OPTICAL AKTIIA BRACELET IN DIFFERENT BODY POSITIONS FOR THE PERSISTENT MONITORING OF BLOOD PRESSURE
Objective: The diagnosis of hypertension and the adjustment of antihypertensive drugs are evolving from repeated isolated measurements performed at the physician offices to the full phenotyping of patients in real-life conditions. Indeed, epidemiologic data show that prediction of risk is largely improved when blood pressure (BP) is measured out of the doctor’s office. Today, out-of-office measurements of BP are mostly performed by a series of self-measurements done at home over several days (HBPM monitoring), or automatically for 24 hours (ABPM monitoring). None of these approaches allow assessing and tracking the 24 hour hypertensive phenotype of patients in the long term. The aim of this study was to demonstrate that a wearable BP monitor (the CE-marked Aktiia Bracelet) can accurately estimate BP in the most common body positions of daily life and thus become a candidate solution for the long-term BP phenotyping of patients. Design and method: We recruited 91 patients with BP ranging from low to hypertensive levels and compared BP values from the Aktiia Bracelet against auscultatory reference values for four weeks at different body positions according to an extended and adapted ISO 81060-2 protocol. Results: The observed means and standard deviations of differences for systolic BP were of 0.46 ± 7.75 mmHg in the sitting position, -2.44 ± 10.15 mmHg in the lying, -3.02 ± 6.10 mmHg in the sitting with the device on the lap, and -0.62 ± 12.51 mmHg in the standing position. Differences for diastolic BP readings were respectively of 0.39 ± 6.86 mmHg, -1.93 ± 7.65 mmHg, 4.22 ± 6.56 mmHg and -4.85 ± 9.11 mmHg. For the sitting and relax position (for which the ISO 81060–2 performance criteria are applicable) the Aktiia Bracelet met criterion 1 and criterion 2. Conclusions: This study demonstrates that the optical Aktiia Bracelet can accurately estimate BP in the most common body positions compared to auscultation, although precision varies across positions. These findings pave the way to the use of this wearable device for the persistent monitoring of BP, and the further identification of individual BP phenotypes at scale.